Real-life use of Rivaroxaban in the Netherlands: data from the Xarelto for Prevention of Stroke in Patients with Atrial Fibrillation (XANTUS) registry

R. Pisters*, S. P. G. van Vugt, M. A. Brouwer, A. Elvan, W. L. ten Holt, P. A. G. Zwart, P. Kirchhof, H. J. G. M. Crijns, M. E. W. Hemels

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)551-558
Number of pages8
JournalNetherlands Heart Journal
Volume25
Issue number10
DOIs
Publication statusPublished - Oct 2017

Keywords

  • Atrial fibrillation
  • Rivaroxaban
  • XANTUS
  • Non-VKA oral anticoagulation
  • RANDOMIZED CONTROLLED-TRIAL
  • ORAL ANTICOAGULATION
  • WARFARIN
  • AF
  • DABIGATRAN
  • APIXABAN
  • OUTCOMES
  • ASPIRIN

Cite this